Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model

Taleen S. Der-Ghazarian, Delaram Charmchi, Sean N. Noudali, Samantha N. Scott, Michael C. Holter, Jason Newbern, Janet Neisewander

Research output: Contribution to journalArticle

Abstract

5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice. We subsequently examined the potential brain regions involved in CP94253 effects using FOS as a marker of neural activity. In the acquisition experiment, mice received the agonist 30 min before each of the Meth injections given during conditioning. In the expression experiment, mice that had acquired Meth-CPP were given either saline or CP94253 and were tested for CPP 30 min later. We found that CP94253 attenuated the expression of Meth-CPP, but had no effect on acquisition. Mice expressing Meth-CPP had elevated numbers of FOS+ cells in the ventral tegmental area (VTA) and basolateral amygdala (BlA) and reduced FOS+ cells in the central amygdala (CeA) compared to saline controls. CP94253 given before the expression test, but not acutely in drug-naive mice, enhanced FOS+ cells in the VTA, the nucleus accumbens (NAc) shell and core, and the dorsomedial striatum and reversed the Meth-conditioned changes in FOS in the BlA and CeA. Approximately 50-70% of FOS+ cells in the NAc and VTA were GABAergic regardless of group. By contrast, we did not observe FOS-labeling in dopamine neurons in the VTA. The findings suggest that CP94253 attenuates the motivational effects of the Meth-associated environment and highlight the amygdala, VTA, NAc, and dorsomedial striatum as potential regions involved in this effect.

Original languageEnglish (US)
Pages (from-to)3271-3283
Number of pages13
JournalACS chemical neuroscience
Volume10
Issue number7
DOIs
StatePublished - Jul 17 2019

Fingerprint

Receptor, Serotonin, 5-HT1B
Serotonin 5-HT1 Receptor Agonists
Methamphetamine
Ventral Tegmental Area
Networks (circuits)
Nucleus Accumbens
Tegmentum Mesencephali
Motivation
Dopaminergic Neurons
Inhibition (Psychology)
Amygdala
Cell Nucleus
Reward
Labeling
Neurons
Rodentia
Dopamine
Brain
Cell Count
Experiments

Keywords

  • CP94253
  • drug-seeking behavior
  • FOS
  • immediate early gene expression
  • incentive motivation
  • reward
  • serotonin

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model. / Der-Ghazarian, Taleen S.; Charmchi, Delaram; Noudali, Sean N.; Scott, Samantha N.; Holter, Michael C.; Newbern, Jason; Neisewander, Janet.

In: ACS chemical neuroscience, Vol. 10, No. 7, 17.07.2019, p. 3271-3283.

Research output: Contribution to journalArticle

Der-Ghazarian, Taleen S. ; Charmchi, Delaram ; Noudali, Sean N. ; Scott, Samantha N. ; Holter, Michael C. ; Newbern, Jason ; Neisewander, Janet. / Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model. In: ACS chemical neuroscience. 2019 ; Vol. 10, No. 7. pp. 3271-3283.
@article{1c7517bb9fd942828e50d381913bb832,
title = "Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model",
abstract = "5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice. We subsequently examined the potential brain regions involved in CP94253 effects using FOS as a marker of neural activity. In the acquisition experiment, mice received the agonist 30 min before each of the Meth injections given during conditioning. In the expression experiment, mice that had acquired Meth-CPP were given either saline or CP94253 and were tested for CPP 30 min later. We found that CP94253 attenuated the expression of Meth-CPP, but had no effect on acquisition. Mice expressing Meth-CPP had elevated numbers of FOS+ cells in the ventral tegmental area (VTA) and basolateral amygdala (BlA) and reduced FOS+ cells in the central amygdala (CeA) compared to saline controls. CP94253 given before the expression test, but not acutely in drug-naive mice, enhanced FOS+ cells in the VTA, the nucleus accumbens (NAc) shell and core, and the dorsomedial striatum and reversed the Meth-conditioned changes in FOS in the BlA and CeA. Approximately 50-70{\%} of FOS+ cells in the NAc and VTA were GABAergic regardless of group. By contrast, we did not observe FOS-labeling in dopamine neurons in the VTA. The findings suggest that CP94253 attenuates the motivational effects of the Meth-associated environment and highlight the amygdala, VTA, NAc, and dorsomedial striatum as potential regions involved in this effect.",
keywords = "CP94253, drug-seeking behavior, FOS, immediate early gene expression, incentive motivation, reward, serotonin",
author = "Der-Ghazarian, {Taleen S.} and Delaram Charmchi and Noudali, {Sean N.} and Scott, {Samantha N.} and Holter, {Michael C.} and Jason Newbern and Janet Neisewander",
year = "2019",
month = "7",
day = "17",
doi = "10.1021/acschemneuro.8b00709",
language = "English (US)",
volume = "10",
pages = "3271--3283",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Neural Circuits Associated with 5-HT1B Receptor Agonist Inhibition of Methamphetamine Seeking in the Conditioned Place Preference Model

AU - Der-Ghazarian, Taleen S.

AU - Charmchi, Delaram

AU - Noudali, Sean N.

AU - Scott, Samantha N.

AU - Holter, Michael C.

AU - Newbern, Jason

AU - Neisewander, Janet

PY - 2019/7/17

Y1 - 2019/7/17

N2 - 5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice. We subsequently examined the potential brain regions involved in CP94253 effects using FOS as a marker of neural activity. In the acquisition experiment, mice received the agonist 30 min before each of the Meth injections given during conditioning. In the expression experiment, mice that had acquired Meth-CPP were given either saline or CP94253 and were tested for CPP 30 min later. We found that CP94253 attenuated the expression of Meth-CPP, but had no effect on acquisition. Mice expressing Meth-CPP had elevated numbers of FOS+ cells in the ventral tegmental area (VTA) and basolateral amygdala (BlA) and reduced FOS+ cells in the central amygdala (CeA) compared to saline controls. CP94253 given before the expression test, but not acutely in drug-naive mice, enhanced FOS+ cells in the VTA, the nucleus accumbens (NAc) shell and core, and the dorsomedial striatum and reversed the Meth-conditioned changes in FOS in the BlA and CeA. Approximately 50-70% of FOS+ cells in the NAc and VTA were GABAergic regardless of group. By contrast, we did not observe FOS-labeling in dopamine neurons in the VTA. The findings suggest that CP94253 attenuates the motivational effects of the Meth-associated environment and highlight the amygdala, VTA, NAc, and dorsomedial striatum as potential regions involved in this effect.

AB - 5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice. We subsequently examined the potential brain regions involved in CP94253 effects using FOS as a marker of neural activity. In the acquisition experiment, mice received the agonist 30 min before each of the Meth injections given during conditioning. In the expression experiment, mice that had acquired Meth-CPP were given either saline or CP94253 and were tested for CPP 30 min later. We found that CP94253 attenuated the expression of Meth-CPP, but had no effect on acquisition. Mice expressing Meth-CPP had elevated numbers of FOS+ cells in the ventral tegmental area (VTA) and basolateral amygdala (BlA) and reduced FOS+ cells in the central amygdala (CeA) compared to saline controls. CP94253 given before the expression test, but not acutely in drug-naive mice, enhanced FOS+ cells in the VTA, the nucleus accumbens (NAc) shell and core, and the dorsomedial striatum and reversed the Meth-conditioned changes in FOS in the BlA and CeA. Approximately 50-70% of FOS+ cells in the NAc and VTA were GABAergic regardless of group. By contrast, we did not observe FOS-labeling in dopamine neurons in the VTA. The findings suggest that CP94253 attenuates the motivational effects of the Meth-associated environment and highlight the amygdala, VTA, NAc, and dorsomedial striatum as potential regions involved in this effect.

KW - CP94253

KW - drug-seeking behavior

KW - FOS

KW - immediate early gene expression

KW - incentive motivation

KW - reward

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=85070025660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070025660&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00709

DO - 10.1021/acschemneuro.8b00709

M3 - Article

VL - 10

SP - 3271

EP - 3283

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 7

ER -